08:56 AM EST, 11/13/2024 (MT Newswires) -- Zentalis Pharmaceuticals ( ZNTL ) said Wednesday it appointed Julie Eastland to succeed Kimberly Blackwell as chief executive officer.

Blackwell will remain as a strategic advisor to the board of directors, the biopharmaceutical company said. .

Eastland previously served as CEO at Harpoon Therapeutics until Merck's ( MRK ) acquisition in early 2024, Zentalis said.

Ingmar Bruns was also appointed chief medical officer, and Scott Myers has been appointed chairperson of Zentalis' board of directors.